Financhill
Back

Inhibrx Stock Predictions

Inhibrx Stock Forecast

  • Over the next 52 weeks, Inhibrx has on average historically fallen by 4.1% based on the past 2 years of stock performance.
  • Inhibrx has fallen lower in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Inhibrx Stock Undervalued?
    The current Inhibrx [INBX] share price is $38.06. The Score for INBX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • INBX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Inhibrx Stock Go Up Next Year?

  • Over the next 52 weeks, Inhibrx has on average historically fallen by 4.1% based on the past 2 years of stock performance.

Inhibrx Stock Rating

Buy
52
Inhibrx (INBX) is a Buy

Is Inhibrx overpriced?

  • Inhibrx has fallen lower in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Inhibrx Stock Price History

Is INBX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and INBX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
inhibrx.com

52-Week Data

52-Week High:
39.50
52-Week Low:
14.31

Prediction Charts

Market Cap:
1.8B
Price in USD:
38.06
Volume:
300.82K
Beta:
3.00

Technical Analysis

SMA50:
34.47
SMA100:
26.59
SMA200:
24.65
52-Wk Change:
58.91%

Stock Predictions

  • Is Inhibrx stock public?
    Yes, Inhibrx is a publicly traded company.
  • What is the Inhibrx stock quote today?
    The Inhibrx stock price is 38.06 USD today.
  • How to buy Inhibrx stock online?
    You can buy Inhibrx shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-31 38.61 38.53 38.83 38.12
Feb-1 38.72 37.97 39.00 37.70
Feb-2 37.68 37.27 38.11 37.27
Feb-5 37.00 38.39 38.39 36.88
Feb-6 38.35 38.60 38.71 37.94
Feb-7 38.71 37.75 38.95 37.62
Feb-8 37.75 37.26 38.17 37.05
Feb-9 37.23 37.40 38.00 37.00
Feb-12 37.68 37.87 38.00 37.07
Feb-13 37.06 37.27 37.49 37.05
Feb-14 37.71 37.57 37.89 37.36
Feb-15 37.78 37.99 38.58 37.60
Feb-16 37.80 37.66 38.19 37.58
Feb-20 37.51 38.06 38.10 37.40

Inhibrx Earnings

Inhibrx Earnings Report: Per Share Inhibrx Earnings Q1 Q2 Q3 and Q4 last year and next year.

Inhibrx Forecast Revenue Growth

Inhibrx Stock Analysis: Historical quarterly revenues per share for Inhibrx and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $0.28 per share.

* Inhibrx stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.